Đánh giá sử dụng thuốc trong điều trị viêm khớp dạng thấp tại Khoa Nội thận - Cơ xương khớp Bệnh viện Trung ương Huế

Abstract

The drug use ofDMARD (Disease Modifying Anti Rheumatic Drug) at the Nephrology- Musculoskeletal Department of Hue Central Hospital was evaluated on 26 patients with rheumatoid arthritis (RA). The rates of indication and dosage in accordance with the guidelines were above 68% and 95%, respectively. After 6 months’ treatment, the C-reactive protein and hemoglobin levels were improved from the baseline. Transaminase increased to grade 1 in 9.1% - 38.1% of the patients. In neutrophil count, decrease was observed in 5.3% - 31.7% of the patients. The major abnormalities were grade 1 neutropenia and grade 2 neutropenia. As a result, for appropriate management of drug use in general, better Monitoring Adverse Drug Reaction in RA patients was required.